EJNMMI Radiopharmacy and Chemistry (Apr 2022)

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

  • Emerson Bernardes,
  • Peter Caravan,
  • R. Michael van Dam,
  • Winnie Deuther-Conrad,
  • Beverley Ellis,
  • Shozo Furumoto,
  • Benjamin Guillet,
  • Ya-Yao Huang,
  • Hongmei Jia,
  • Peter Laverman,
  • Zijing Li,
  • Zhaofei Liu,
  • Filippo Lodi,
  • Yubin Miao,
  • Lars Perk,
  • Ralf Schirrmacher,
  • Johnny Vercoullie,
  • Hua Yang,
  • Min Yang,
  • Xing Yang,
  • Junbo Zhang,
  • Ming-Rong Zhang,
  • Hua Zhu

DOI
https://doi.org/10.1186/s41181-022-00162-3
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 17

Abstract

Read online

Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results This commentary of highlights has resulted in 23 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals and also a contribution in relation to MRI-agents is included. Conclusion Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Keywords